Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. [electronic resource]
Producer: 20050624Description: 3502-8 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bevacizumab
- Colorectal Neoplasms -- drug therapy
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Humans
- Leucovorin -- administration & dosage
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Invasiveness -- pathology
- Neoplasm Metastasis
- Neoplasm Staging
- Probability
- Prognosis
- Risk Assessment
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.